Transcript Dr. Siegfried Bialojan

Dr. Siegfried Bialojan
Dr. Siegfried Bialojan
Executive Director
Head of EY Life Science Center in Mannheim, Germany
Close collaboration with EY Global Life Science Center in
New York/ Boston
Sponsoring member of
Bio Deutschland (German biotech industry association)
Ernst & Young GmbH
Wirtschaftsprüfungsgesellschaft
Theodor-Heuss-Anlage 2
68165 Mannheim
Germany
Tel
Mobile
Fax
Email
+49 621 4208 11405
+49 160 9391 11405
+49 621 4208 42102
[email protected]
Background
Skills
Role at EY
Areas of expertise
Projects
►
In depth life science industry experience (trends,
strategies, processes)
►
►
Experience in business assessment (technology, IP,
product portfolio, market, competitiveness, regulatory
compliance)
►
• In charge of life science knowledge platform (global life
science database, team of scientists with industry
experience)
• Conducting global industry surveys and annual life
sciences industry analysis
• Providing input to EY´s biotech and medtech thought
►
leadership reports
• Assisting advisory client projects as an industry expert
(transactions, performance improvement, risk
management, assurance)
Prior to joining EY
►
14 years in the pharmaceutical industry
►
►
Relationships and contacts to international pharma
and biotech executives
►
Strengths in relationship building and business
development
►
Post-doc scientist at German Cancer Research Institute;
Heidelberg
►
Structured and strategic thinking
cell biology research
►
Project and team management
►
PhD from University of Heidelberg
►
Languages
molecular biology, human medicine (medical school)
Annual EY thought leadership Reports
German biotechnology report, global biotechnology report,
global medical technology report
International benchmark studies
life science strategies for several European countries /
regions
►
Broad relationship network in life sciences industry
(companies, investors and industry associations)
Personal skills and competences
BASF Pharma / Knoll AG, Abbott
In various functions: drug discovery research, drug
screening, drug development (ADME), R&D management
Go-to-market and project execution support, primarily
in M&A, due diligence, valuation as well as advisory
projects
Professional experience
Business assessments of European Life Science
companies (pharma, biotech, medtech)
technologies, product portfolio, market, business plan,
business risks, compliance
►
Transaction advisory support
M&A, due diligence, valuation, purchase price allocation
►
Business advisory support
R&D portfolio management / operational excellence
German – mother tongue
English – fluent in writing and speaking
French – good understanding, basic in speaking
1